as previously described in detail (4) . Affinity-purified anti-ovalbumin (anti-OVA) antibody was prepared in a similar manner from the pooled serum of rats immunized with OVA. Antibody concentrations were measured by enzyme-linked immunoassay, as previously described (4) , and adjusted to 6 mg/ml. Normal rat gamma globulin (NRGG) was prepared from normal rat serum by the method of Stuart et al. (3) .
Induction of Arthritis. AA was induced with 100% incidence in 5-10-wk-oid LEW rats of either sex by a single intradermal injection into the tail, of a suspension of 0.6 mg Mycobacterium butyricum (Difco Laboratories, Inc., Detroit, MI) in oil (CFA), prepared as previously described (11) . CIA was induced with >90% incidence by a modification of the method of Stuart et al. (3) ; in brief, rats were given two intradermal injections, 1 wk apart, of 0.2 mg CII in incomplete Freund's adjuvant into the tail.
Cell Cultures. Lymph node (LN) and spleen cell suspensions, prepared as previously described (11) , were cultured 1-3 d (usually 2 d) in Dulbecco's modified Eagle's medium (M. A. Bioproducts, Walkersville, MD) containing 4.5 g/liter of glucose, 10 mM Hepes, 50 #g/mi penicillin, 50 /~g/ml amikacin (Bristol Laboratories Div., Bristol-Myers Co., Syracuse, NY), 5% horse serum (K.C. Biological, Inc., Lenexa, KA), and 2 ~g/ml concanavalin A (Con A) (Miles-Yeda, Rehovot, Israel), at 2 x 10 ~ celis/ml in 150-cm ~ flasks, at 37°C in a humidified 95% air/5% COs atmosphere. In some experiments, phytohemagglutinin (PHA-M; Difco Laboratories, Inc.), 1% vol/vol, was substituted for Con A in cultures of AA lymphoid cells.
Injections. 6-10-wk-old LEW/SsN rats of either sex were given intravenous injections of anti-CII or control antibodies in phosphate-buffered saline and/or lymphoid cells in serum-free culture medium. Cells irradiated just before transfer were exposed to either 1,000 or 1,500 rad from a ~S~Cs source (J. L. Shepherd & Associates, Glendale, CA).
Evaluation of Arthritis.
After injection of cells and/or antibody, rats were clinically evaluated three to six times per week until the end of the experiment. In initial experiments, it became clear that diffuse, symmetric involvement of every joint of the four paws was a major effect of the synergistic arthritis. To quantitate this arthritis most accurately, a scoring system was devised in which each joint was separately evaluated for swelling and erythema; this system is outlined in Table I . The knee was excluded because neither swelling nor erythema of the knee could be reliably quantitated by physical examination. Radiography. Radiographs were prepared as previously described (10) , and scored blindly by one observer (MLM); abnormalities were graded as follows: periosteai reaction, 0-3 (none, slight, moderate, marked); erosions, 0-3 (none, few, many small, many large); joint space narrowing, 0-3 (none, minimal, moderate, marked); joint space destruction, 0-3 (none, minimal, extensive, ankylosis).
Histopathology. Tissues were fixed in 10% neutral-buffered formalin. Larynges and ears were embedded in paraffin. As previously described (4), paws were decalcified in EDTA, then embedded in methacrylate and sectioned at 3-4/~m; sections were stained with a modified Giemsa (American Histolabs, Rockviile, MD).
Immunofluorescence. Frozen sections were prepared from hindpaws and studied for immunoglobulin and C3 deposition, as previously described in detail (4) . Formal evaluation of immunofluorescence and histopathology was carried out blindly by one observer (RAM).
Statistics. Paired means were compared by Student's t test. Three or more group means were compared by one-way analysis of variance, with an assumed significance level ofP < 0.05 (14) .
Results
Synergy Between Passively Administered Cells and Antibody. (Tables II-IV, and Figs. 1 and 2). Synergy between AA and CIA was observed when normal LEW rats were intravenously given varying amounts of anti-CII, followed within 1 d by varying numbers of adjuvant-sensitized, Con A-stimulated (AA/Con A) syngeneic LN or spleen cells. The arthritis induced by anti-CII and AA/Con A cells appeared 3-6 d after cell transfer. In most instances, every joint of the four paws showed severe swelling and erythema (Fig. 1) . The arthritis peaked in severity within 2 wk of cell administration; after 3 wk, the erythema generally began to subside; residual deformity, including widespread joint ankylosis, was the rule after 6 wk or more. In rats not given anti-CII, AA/Con A LN or spleen cells induced a moderately severe, asymmetric arthritis that tended to affect primarily the ankles, midtarsal regions, and, to a lesser extent, the wrists; the small joints of the hind-and forepaws were much less often involved ( Fig. 1 ; Table II , group E, and Table III , group L), as previously described (10, 11) . In rats given both AA/Con A spleen cells and anti-CII, increasingly severe arthritis resulted with coadministration of increasing doses of AA/Con A lymphoid cells and increasing doses of anti-CII ( Fig. 2 ; Table II , groups C and D; and data not shown). In contrast, in rats given AA/Con A LN cells (Table III , group J) no significant differences in the severity of the arthritis resulted from doses of anti-CII of 6, 12, or 24 mg (separate peak joint scores, 130 + 15, 124 __+ 21, and 150 _+ 8, respectively; P > 0.05). This may have been due to the generally larger doses of LN cells given. Some synergy was also observed when large numbers of uncultured LN or spleen cells were transferred directly from AA donors to recipients simultaneously given anti-CII (Table II, groups H and I; Table III , groups M and N), although the arthritis was significantly less severe than that of rats receiving anti-CII and AA/Con A cells.
Given without cells, 24 mg of anti-CII reproducibly induced within 24 h a mild, symmetrical hindfoot arthritis that rarely lasted >1 wk (Table II, mg anti-CII caused no detectable arthritis (Table II, g r o u p B). T h e ability of administered anti-CII to synergize with A A / C o n A cells persisted for at least 4 wk, the longest time interval examined (Table III, g r o u p K).
T h e synergy between anti-CII and AA lymphoid cells in the induction of arthritis showed specificity. No synergy was seen when either N R G G in doses up to 100 m g or 24 m g of affinity-purified anti-OVA was given with A A / C o n A cells (Table IV , groups O -Q ) . Con A -s t i m u l a t e d lymphoid cells f r o m LEW rats with C I A showed neither arthritogenicity when given alone nor synergy when given with anti-CII, n o r was there evidence of synergy between anti-CII and Con A -s t i m u l a t e d cells f r o m normal L E W rats (Table IV, 
groups T -W ) .
By far the most severe arthritis and most striking synergy were seen in recipients o f anti-CII and AA LN or spleen cells cultured with Con A; AA cells Procedures were as described in the legend to Table II , except for group K, as noted below. * GroupJ > K> M > L = N. * AA/Con A LN cells were given 4 wk after anti-CII. cultured with PHA-M were much less effective in synergizing with anti-CII than AA cells cultured with Con A (Table IV, induced arthritis, rats with actively induced AA or CIA were reciprocally given either anti-CII or AA/Con A spleen cells. Within 2 d of administration of 12 mg of anti-CII to rats with established AA, a marked, sustained increase in arthritic severity occurred (Fig. 3) . Normal rat gamma globulin had no significant effect. Similarly, administration of 5 X 107 AA/Con A spleen cells to rats with established CIA produced a marked, sustained increase in arthritic severity (Fig. 4) , while irradiated AA/Con A spleen cells from the same cultures had no effect. Administration of 5 x 107 Con A-stimulated AA spleen cells to rats with established, actively induced AA had no effect on the severity or course of the disease (data not shown).
Synergy Between the Two Active Diseases. To determine if synergy could occur between actively induced AA and CIA, conventional doses of CFA and CII were separately administered to groups of rats, either simultaneously or 2 wk apart. As shown in Fig. 5 , the arthritic severity of rats simultaneously given CFA and CII exceeded the sum of the arthritic scores of rats given each agent alone. Rats that received the two agents 2 wk apart showed biphasic arthritic responses, with arthritic scores that were essentially additive when compared with the scores of rats receiving each agent alone. Rats receiving both CFA and CII consistently showed diffuse, symmetric involvement of the small joints of the forepaws that was not seen in either of the two control groups. Days after Antibody Injection FIGURE 3. Synergistic effect of anticollagen antibody on actively induced AA. 10 rats were injected with CFA on day -13; on day 0, all rats had arthritis and were randomly selected to receive intravenously either 12 mg of anti-CII (four rats), 12 mg of NRGG (four rats), or nothing (two rats). One rat in the group receiving anti-CII died after anesthesia for roentgenography on day 13. The anti-CII-treated group was significantly different from the other two groups at each point past day 2 (P < 0.05). Similar results were obtained in a second experiment. shown). In contrast, radiographic abnormalities developed in animals receiving AA/Con A cells alone or in conjunction with anti-CII. These results are summarized in Table V and illustrated in Figs. 6 and 7.
Radiographic Evaluation of Passively Transferred Arthritis. Rats given arthritogenic doses of anti-CII alone showed no radiographic changes (results not
In rats given AA/Con A cells alone, abnormalities consisted of asymmetric soft tissue swelling and small erosions, periosteal thickening, and minimal joint space narrowing, predominantly localized to the proximal areas of the paws (Figs. 6 a,  7a) . At 3 mo, these rats had developed definite joint space narrowing of the intertarsal joints ( Fig. 6 b) ; forepaw changes were not apparent (Fig. 7 b) .
In contrast to the mild changes induced by AA/Con A cells alone, marked changes were present in the recipients of both AA/Con A cells and anti-CII. At 19 d, changes in these rats consisted of diffuse soft tissue swelling that included the digits, diffuse demineralization of bone, marked periosteal thickening, and cystic enlargement of bone. Extensive erosions produced narrowing or pseudowidening of all joint spaces (Figs. 6c, 7c) . By 7 wk, soft tissue swelling had diminished, bones were denser, and bony enlargement was more pronounced. Joint space destruction, pseudo-widening, ankylosis, and subluxation were widespread. These changes persisted upon examination at 3 mo (Figs. 6d, 7d) . In rats given both CFA and CII (Fig. 5) , radiographic changes were qualitatively similar to those shown in Figs. 6 c, 6 d, 7 c, and 7 d (data not shown).
Immunofluorescence. Rats injected with 12 mg anti-CII, with or without AA/ Con A cells, and sacrificed on the second or fourth day after injection, showed bright linear fluorescence for IgG along the articular surfaces of their intertarsal joints; slight but definite fluorescence for C3 was also present in several of these rats. These findings were very similar to those previously reported (4). Rats FIGURE 5. Synergy between actively induced AA and actively induced CIA. Data have been pooled from a total of three experiments. In each experiment, rats were divided into five groups and given: CFA alone, CI1 in IFA alone, CFA and CII together, CFA followed 2 wk later by CII, and CII followed 2 wk later by CFA. Rats given CII were boosted 1 wk after the first injection, as described in Materials and Methods. Each point represents the composite mean + SD arthritis score for all arthritic animals in the indicated treatment group during the time period indicated. 2 of 14 rats given CII alone failed to develop arthritis and have been excluded from the computations; all rats in all other groups developed arthritis. (*) Significantly different from both control groups at this and all subsequent time points. (11) CFA alone (n ---13); (A) CII alone (n = 12); (©) CFA + CII on day 0 (n = 14); (A) CFA on day 0, CII on day 14 (n -14); (0) CII on day 0, CFA on day 14 (n = 14). All rats were given either 3-4 x 107 AA/Con A spleen cells or 1 x l0 s AA/Con A LN cells; rats in group B also received 6-24 mg anti-CII. Radiographs taken at the time points indicated were scored blindly as described in Materials and Methods. Data represent mean + SD of the scores for all rats in each group. Numbers in parentheses represent the number of rats radiographed in each group at each time point. All paired comparisons between groups A and B at each time point are significant at P < 0.001.
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receiving AA/Con A cells alone had no detectable IgG or C3 binding to joint structures.
Histopathology. Intertarsal joints from rats given anti-CII alone, AA/Con A cells alone, or both agents together, were examined serially (Fig. 8) . By day 2 after the administration of AA/Con A cells plus anti-CII, pathologic changes The proximal phalanges remained enlarged and some erosions persisted in the MCP and PIP joints. The carpal bones had almost completely dissolved, and bony lysis had also caused shortening of the distal ulna and radius. consisted of infiltration of a few neutrophils into mildly edematous synovium. By day 4, destructive lesions were evident in articular cartilage (Fig. 8a) . By day 6, there was frank exudation into the joint space, more extensive erosion of articular cartilage by neutrophils, and marginal erosion of subchondral bone ( Fig. 8 b) ; these destructive changes were more extensive on day 10 (Fig. 8 c) . By day 21, the acute, exudative changes had subsided; residual destruction of cartilage and cortical bone, and florid osteoneogenesis, were characteristic findings (Fig. 8, d and e). Rats receiving AA/Con A cells alone had minimal inflammatory changes by day 4; these had progressed only slightly by day 10. By day 21, mild osteoneogenesis was apparent (Fig. 8f) . Rats receiving anti-CII alone showed minimal inflammatory changes on day 4 only. No pathologic changes were found in the larynges or ears of any rat, whether treated with anti-CII, AA/Con A cells, or both.
Discussion
Although adjuvant arthritis has been extensively studied since it was first observed three decades ago (7), no specific inciting or target antigen has been convincingly implicated in the pathogenesis of the disease. Nonetheless, the evidence that a cell-mediated immune response is primarily responsible for AA is quite strong, and several investigators have demonstrated that lymphoid cells derived from adjuvant-treated rats can adoptively transfer inflammatory arthritis (10) (11) (12) (13) (15) (16) (17) . In most of these systems, some manipulation of either the transferred cells or the recipients or both has been necessary to obtain reproducible transfer of arthritis. Such manipulation has included coadministration of transferred cells with a subarthritogenic dose of adjuvant (17) , treatment of the transferred cells with Con A in vitro (10, 1 1), transfer of mycobacterial antigenspecific T cell lines (12, 13) , and immunosuppression of the recipients (10, 12, 13) . In all of these systems, the passively transferred arthritis generally is less severe and involves fewer joints than in conventional, actively induced AA.
One interpretation of these results posits that the manipulations are necessary to overcome the resistance of the normal host synovium to the induction of inflammation by the transferred cells, in contrast to actively induced AA, in which the pro-inflammatory adjuvant has been shown to disseminate to joint tissues (18) . We reasoned that, if local synovial alterations promote arthritis induced by AA lymphoid cells, then the administration of antibody to type II collagen, which has been shown to bind rapidly in vivo wherever there is articular cartilage (19) and to produce transient inflammation in large joints (3) (4) (5) , should augment the severity of the arthritis passively transferred with AA cells.
This prediction was borne out in the experiments described in this paper; in normal rats given anti-CII and AA lymphoid cells, we observed a striking, synergistic arthritis as a specific and dose-dependent effect of the two components. Compared with the arthritis induced by transfer of either AA cells alone or anti-CII alone, this synergy was manifested clinically by earlier and more abrupt onset of arthritis, and by more prominent, diffuse, and symmetric swelling and erythema; histological manifestations were an earlier, more diffuse, and far more phlogistic and erosive appearance; and radiographic manifestations were more diffuse and intensive joint destruction and reactive osteoneogenesis. Similar results were seen when rats with active AA or CIA were given the reciprocal passive component, and when both active diseases were induced in the same hosts.
From these data we may draw the following conclusions: (a) antibody to type II collagen, bound to articular cartilage, can serve as a latent arthritogen in virtually any synovial joint by interacting with specifically stimulated cellular components; (b) lymphoid cells from AA rats have a substantially greater capacity than do lymphoid cells from CIA rats to induce severe, destructive arthritis; (c) AA and CIA are pathogenetically distinct diseases.
Several possible mechanisms can be envisioned for the observed synergy. The antibody on the articular surface probably serves to focus within the joint a variety of cells bearing Fc receptors. Complement fixation by the bound IgG could be expected to increase synovial vascular permeability and neutrophil migration into the joint; this in turn would be expected to render the joint more susceptible to the entry and pro-inflammatory effects of cytokine-secreting lymphoid cells.
The passive transfer experiments presented here did not address the relative effector roles of the administered cells and of recruited host cells; although the vast majority of the administered cells were lymphocytes or lymphoblasts, the predominant cells in the early lesions of the synergistic passive arthritis were neutrophils and macrophages. Indeed, we have only indirect evidence that the administered AA cell population contained effector cells that themselves traffic to joints. We have observed that AA/Con A LN or spleen cells induce passive arthritis equally well in intact, splenectomized, or sham-splenectomized recipients; however, our efforts by a variety of methods to directly demonstrate specific trafficking of AA/Con A lymphoid cells to joints have all failed (unpublished results). At present, we speculate that relatively few AA effector cells are necessary for induction of arthritis in a particular joint, especially in the case of synergy with anti-CII.
Con A-stimulated cells from rats with CIA were found not to synergize with anti-CII, nor were they arthritogenic when given alone (Table IV) . In other experiments, we obtained the same negative results with large numbers (>5 × 108) of CIA LN and spleen cells transferred directly, and with CIA cells cultured in vitro with type II collagen (unpublished results). These results conflict with those of Trentham et al. (20) , who observed that large numbers of CIA LN and spleen cells could transfer arthritis in LEW rats. While the explanation for this difference is not apparent, there is substantial evidence for the participation of cell-mediated immune mechanisms in the pathogenesis of collagen-induced arthritis (21) (22) (23) , including the direct demonstration of T lymphocytes in the synovium of rats with CIA (24) . However, the data from our passive transfer experiments suggest that, in AA, the destructive capacity of the cellular immune responses is substantially greater than in CIA.
The conclusion that AA and CIA have different pathogenetic mechanisms is consistent with the findings of several investigators, who have reported that significant levels ofanti-CII do not develop in AA rats (25) (26) (27) , that arthritogenic cloned antimycobacterial T cells do not react with type II collagen (13) , and that AA and CIA are not susceptible to cross-tolerization (21, 25, 26) . While there have also been reports of suppression of AA by administration of CII (27, 28) , these reports are not necessarily in conflict with our findings or conclusions, since the mechanism of this suppression may not be antigen-specific.
We have found only one other report of a positive interaction between humoral and cellular mechanisms in the passive transfer of experimental autoimmune disease (29) . However, in complex human diseases, it is likely that several indepenent events contribute to disease expression. Synergistic mechanisms such as we have demonstrated may operate in human rheumatoid arthritis, in which accumulations of both intrasynovial immune complexes and inflammatory mononuclear cells are readily observed (30) . It is conceivable that the effect of anti-CII in our synergy model is not specific; rather, the critical factor may be a high density of intrasynovial immunoglobulin of the proper isotype, which, independently of its antigenic specificity, provides a matrix of in situ immune complexes that promotes cell-mediated inflammation and destruction, analogous to the situation in rheumatoid arthritis (30, 31) . Further experimentation with this model should produce better understanding of its mechanisms and its application to human disease.
Summary
Adjuvant arthritis (AA) in rats is susceptible to cell-mediated passive transfer. Collagen-induced arthritis (CIA) in rats is susceptible to passive transfer with antibody to type II collagen. We report here the development of strikingly severe arthritis in Lewis rats as the result of synergy between passively transferred antibody to type II collagen from rats with CIA and concanavalin A (Con A)-stimulated lymph node or spleen cells from syngeneic rats with AA. Similar synergy was seen in rats with AA given anticollagen antibody, in rats with CIA given Con A-stimulated adjuvant spleen cells, and in rats actively immunized with CII and complete Freund's adjuvant. The synergistic process caused a very severe polyarthritis, characterized by marked swelling and erythema in all the joints of the distal extremities, with histologic and radiographic evidence of early, extensive erosion of articular cartilage. Synergy was apparent if the lymphoid cells from AA rats were given up to 1 mo after a single injection of anticollagen antibody. No synergy was seen when normal rat immunoglobulin or antiovalbumin antibody was substituted for anticollagen antibody, when Con A-stimulated lymphoid cells from normal rats or donors with CIA were used, or when Con A-stimulated AA lymphoid cells were irradiated before transfer. Synergy between separate immune effector mechanisms may represent a general phenomenon in the pathogenesis of inflammatory joint disease.
